Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/05/2010US20100196389 Methods of using corticotropin-releasing factor for the use of the treatment of cancer
08/05/2010US20100196388 Targeted binding agents directed to sonic hedgehog homolog and uses thereof
08/05/2010US20100196386 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
08/05/2010US20100196385 Targeted binding agents directed to dll4 and uses thereof 524
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
08/05/2010US20100196377 Methods of treating, diagnosing or detecting cancer
08/05/2010US20100196373 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy
08/05/2010US20100196370 Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment
08/05/2010US20100196369 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010US20100196365 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
08/05/2010US20100196364 Monoclonal antibodies to fibroblast growth factor receptor 2
08/05/2010US20100196363 Cancer treatment combination therapy comprising vinflunine and trastuzumab
08/05/2010US20100196361 Method of inhibition of vascular development using an antibody
08/05/2010US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant
08/05/2010US20100196358 Method and kit to profile tumors by biomarker analyses including transcriptional factor assays
08/05/2010US20100196357 Microrna modulators and method for identifying and using the same
08/05/2010US20100196356 Tumour Growth Inhibitory Compounds and Methods of their Use
08/05/2010US20100196350 Pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
08/05/2010US20100196339 Microparticle-Based Transfection and Activation of Dendritic Cells
08/05/2010US20100196336 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
08/05/2010US20100196325 Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods
08/05/2010US20100196324 Multifunctional cytokines
08/05/2010US20100196320 Interferon aplpha sequential regimen for treating cancers
08/05/2010US20100196311 METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES
08/05/2010US20100196310 Methods of treating cancer by administering human il-18 combinations
08/05/2010US20100196280 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications
08/05/2010US20100196273 Novel agent for in vivo pet imaging of tumor proliferation
08/05/2010US20100196271 Cage-Like Bifunctional Chelators, Copper-64 Radiopharmaceuticals and PET Imaging Using the Same
08/05/2010US20100196268 Compositions and methods for treatment of tumors by direct administration of a radioisotope
08/05/2010US20100196266 Humanized Anti-HLA-DR Antibodies
08/05/2010US20100196265 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
08/05/2010CA2751068A1 Anti-cancer protein-platinum conjugates
08/05/2010CA2751041A1 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism
08/05/2010CA2750988A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010CA2750944A1 Compositions and methods for the treatment of cancer
08/05/2010CA2750659A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010CA2750086A1 Scriptaid isosteres and their use in therapy
08/05/2010CA2749947A1 Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213740A1 Human telomerase catalytic subunit
08/04/2010EP2213738A2 siRNA molecules targeting Bcl-2
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213736A2 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness
08/04/2010EP2213682A1 TSLP promotes immune evasion and persistence of viruses
08/04/2010EP2213679A1 Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
08/04/2010EP2213674A1 Purification method of pemetrexed salts,sodium salts and disodium salts
08/04/2010EP2213673A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
08/04/2010EP2213670A2 Epothilone derivatives
08/04/2010EP2213667A1 Cephalomannine derivatives and their preparation, medicinal composition and use
08/04/2010EP2213309A1 Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent
08/04/2010EP2213302A2 DR4 antibodies and uses thereof
08/04/2010EP2213301A1 Immune response inducer
08/04/2010EP2213300A1 Composition and method for treating cancer using herpes virus
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2213291A1 Antisense inhibition of PTP1B expression
08/04/2010EP2212338A2 Polymorphic forms of ibandronate sodium and processes for preparation thereof
08/04/2010EP2212333A1 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors
08/04/2010EP2212332A1 Substituted tricyclic compounds and methods of use thereof
08/04/2010EP2212327A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
08/04/2010EP2212326A1 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
08/04/2010EP2212318A1 Thiazole derivatives as protein kinase inhibitors
08/04/2010EP2212311A2 Maleate salts of (e)-n-{4-ý3-chloro-4-(2-pyridinylmethoxy)anilino¨-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
08/04/2010EP2212305A1 Beta-lactone compounds
08/04/2010EP2212301A1 An improved process for preparation of letrozole and its intermediates
08/04/2010EP2211910A2 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
08/04/2010EP2211908A2 Conjugates of anti-rg-1 antibodies
08/04/2010EP2211903A1 Antibodes to cll-1
08/04/2010EP2211902A1 Uses of anti-cd40 antibodies
08/04/2010EP2211897A1 Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)
08/04/2010EP2211894A2 Inhibition of urokinase-type plasminogen activator (upa) activity
08/04/2010EP2211891A2 Antagonists of kisspeptin and uses thereof
08/04/2010EP2211880A1 Treatment regime for proliferative disorders
08/04/2010EP2211878A2 Calcium-mediated effects of coral and methods of use thereof
08/04/2010EP2211871A1 Method for inhibiting angiogenesis or for treatment of cancer
08/04/2010EP2211870A1 Cytidine analogs for treatment of myelodysplastic syndromes
08/04/2010EP2211869A2 Idarubicin for the treatment of lymphoma in a dog
08/04/2010EP2211868A2 Silicate containing compositions and methods of treatment
08/04/2010EP2211862A2 Csf-1r inhibitors for treatment of cancer and bone diseases
08/04/2010EP2211861A1 Clioquinol for the treatment of hematological malignancies
08/04/2010EP2211858A2 Use of quaternary pyridinium salts for inhibiting cancer metastases
08/04/2010EP2211854A1 Methods and compositions for the treatment of cancer using benzopyrone-type parp inhibitors
08/04/2010EP2211615A1 Pyridosulfonamide derivatives as pi3 kinase inhibitors
08/04/2010EP1711618B1 Methods for detecting markers associated with endometrial disease or phase
08/04/2010EP1635863B1 Compositions to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010EP1045853B1 Synthesis of combretastatin a-4 prodrugs
08/04/2010CN1915222B Composition of liposome, and preparation method
08/04/2010CN101796184A Compositions and methods of treating cancer
08/04/2010CN101796073A Humanized antibodies against CXCR3
08/04/2010CN101796056A heterocyclic inhibitors of c-met and uses thereof
08/04/2010CN101796055A Inhibitors of VEGF receptor and HGF receptor signaling
08/04/2010CN101796048A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
08/04/2010CN101796046A Pyrimidine derivatives 934
08/04/2010CN101796045A New chemical compounds
08/04/2010CN101796020A Novel triazine compounds for treatment of cancer
08/04/2010CN101795728A Isoxazole compound for the treatment of cancer
08/04/2010CN101795714A Method for promoting the expression of p53, and p53 expression promoter for use in the method
08/04/2010CN101795712A Pharmaceutical compound
08/04/2010CN101795711A chemical linkers and cleavable substrates and conjugates thereof
1 ... 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 ... 2211